Correction to: Real‑World Evidence of the Safety and Effectiveness of Atogepant Added to OnabotulinumtoxinA for the Preventive Treatment of Chronic Migraine: A Retrospective Chart Review
Saved in:
Main Authors: | Andrew M. Blumenfeld, Laszlo Mechtler, Lisa Cook, Christopher Rhyne, Brian Jenkins, Olivia Hughes, Brett Dabruzzo, Aubrey Manack Adams, Merle Diamond |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2024-12-01
|
Series: | Pain and Therapy |
Online Access: | https://doi.org/10.1007/s40122-024-00692-5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Botox (OnabotulinumtoxinA) for Treatment of Migraine Symptoms: A Systematic Review
by: Negar Shaterian, et al.
Published: (2022-01-01) -
Outcomes following intradetrusor onabotulinumtoxinA in a national cohort of nursing home residents
by: Leo D. Dreyfuss, et al.
Published: (2025-01-01) -
Clinical Pharmacokinetics of Atogepant in Healthy Japanese and White Adults
by: Ramesh R. Boinpally, et al.
Published: (2025-01-01) -
A Study of Combined Onabotulinumtoxin A and Hyaluronic Acid Filler for the Treatment of Enlarged Facial Pores
by: Vasanop Vachiramon, et al.
Published: (2025-01-01) -
Die Bevordering van gemeenskapsverhoudinge deur die suid-afrikaanse polisiediens (ovs-streek) :
by: Rhyne Rhyne Kriek
Published: (2022-11-01)